Companies: 10,795·Total market cap: $144.5T
Isracann Biosciences Inc.

Isracann Biosciences Inc.

ISCNFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1760
P/E Ratio—
52W High$0.0001
52W Low$0.00001
Overview

Isracann Biosciences Inc. (ISCNF) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · ISCNF · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2022-052021-052020-052019-052018-05
Operating Activities
Net Income($0.00B)($0.03B)($0.02B)($0.01B)($0.01B)
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.00B$0.00B
Change in Working Capital$0.00B($0.00B)$0.00B$0.00B$0.00B
Net Cash from Operations($0.00B)($0.00B)($0.01B)($0.00B)($0.00B)
Investing Activities
Capital Expenditure$0.00B($0.00B)($0.00B)($0.00B)($0.01B)
Purchases of Investments$0.00B$0.00B($0.00B)$0.00B$0.00B
Sales of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Investing($0.00B)$0.00B($0.00B)($0.00B)($0.01B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B$0.00B
Dividends Paid$0.00B$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid$0.00B$0.00B$0.00B$0.00B$0.01B
Net Cash from Financing$0.00B$0.00B$0.01B$0.01B$0.02B
Free Cash Flow
Free Cash Flow($0.00B)($0.00B)($0.01B)($0.00B)($0.01B)
FCF Margin %(computed)————-760.20%

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · CAD · B

Explore more Isracann Biosciences Inc. data

Revenue History
Quarterly & annual revenue trends
Earnings Reports
EPS beats, misses & upcoming dates
P/E Ratio
Historical price-to-earnings
Dividends
Dividend history & yield
Market Cap
Historical market cap & rank
Analyst Forecast
Consensus, price targets & estimates

About Isracann Biosciences Inc. (ISCNF) Cash Flow Statement

Isracann Biosciences Inc. generated operating cash flow of ($0.00B) and free cash flow of ($0.00B) for 2022 — a FCF margin of —. Capital expenditure was $0.00B.

Frequently asked questions

ISCNF · 4 questions

Isracann Biosciences Inc. generated free cash flow of ($0.00B) for 2022, up 58.7% year-over-year.

ISCNF free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10